• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

First major study of proteins in patients with acute lymphoblastic leukaemia

Bioengineer by Bioengineer
April 25, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The most common form of childhood cancer is acute lymphoblastic leukaemia (ALL). Researchers at Lund University in Sweden, in cooperation with Karolinska Institutet, SciLifeLab and the University of Cambridge, have now carried out the most extensive analysis to date of ALL at the protein level, by studying the activity in over 8 000 genes and proteins. The results show aberrant folding in the DNA string, which in turn affects the genes’ activity. The study was recently published in Nature Communications.

Approximately 25 per cent of the children who develop ALL have a form of leukaemia that is characterised by the diseased cells containing too many chromosomes, known as hyperdiploidy. Sometimes up to 67 chromosomes are found in a single cell.

“We have previously shown that the genes on the extra chromosomes control the development of leukaemia by becoming more active. This induces an imbalance in the cells which, for example, may then begin to divide faster”, says Kajsa Paulsson, associate professor at Lund University and last author of the study.

However, the exact mechanisms at work have been unclear up to now. In the new study, researchers examined the activity in more than 8 000 genes and proteins – something that had never previously been done on this scale for this form of cancer.

The advantage of examining proteins is that it is more biologically relevant. If only the RNA level is examined and then translated to the protein level, the connection is not completely clear, explains Kajsa Paulsson.

“It is a newer field and examining the protein levels is more difficult, but the advantage is that it gives us a better picture of how the cell is controlled compared with only studying the genes”, says Janne Lehtiƶ, professor at Karolinska Institutet and co-author of the study.

In the hyperdiploid leukaemias, the researchers noted lower levels of the CTCF protein and the protein complex cohesin, which control how the DNA string is folded in the cell, compared with the leukaemias that do not have extra chromosomes. The researchers therefore examined how DNA is folded in hyperdiploid leukaemia and were able to observe that a proportoin of cases showed aberrant folding.

“How DNA is folded is important for the regulation of when genes are to be active or not. We could also see that the hyperdiploid leukaemias showed signs of dysregulated genes, something that probably contributes to the onset of the disease”, says Kajsa Paulsson.

Continuing research will focus on identifying the proportion of DNA that displays aberrant folding. The results of the study are important for understanding how hyperdiploid childhood leukaemia arises and what drives the cancer process.

“Today, there is a 90 per cent cure rate for children with ALL, due to extensive treatment using chemotherapy. In the future, we hope to be able to develop even better treatments that provide an even greater chance of a cure and fewer side effects”, concludes Kajsa Paulsson.

###

Media Contact
Kajsa Paulsson
[email protected]
http://dx.doi.org/10.1038/s41467-019-09469-3

Tags: cancerMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

Interpretable Deep Learning for Anticancer Peptide Prediction

September 13, 2025

Navigating Shadows: Treating Anorexia and C-PTSD

September 13, 2025

Preoperative BMI Influences Outcomes in Infective Endocarditis

September 13, 2025

Adverse Events in Asian Adults on Brivaracetam

September 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Xanthan Gum Production with Essential Oil By-products

Groundwater Pesticide Contamination: Challenges and Solutions

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

  • Contact Us

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.